Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0R44

C-rad Ab (0R44)

C-rad Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R44
DateTimeSourceHeadlineSymbolCompany
05/07/20211:47AMPR Newswire (US)2021 Opens With Growth And Improved ProfitabilityLSE:0R44C-rad Ab
05/04/20211:55AMPR Newswire (US)Reminder: C-RAD Web Presentation Interim Report Q1 2021 and AGM speechLSE:0R44C-rad Ab
04/23/20215:30AMPR Newswire (US)The Patent and Market Court of Appeal issues judgement confirming C-RAD's entitlement to Beamocular's inventionLSE:0R44C-rad Ab
04/23/20211:44AMPR Newswire (US)C-RAD Web Presentation Interim Report Q1 2021 and AGM speechLSE:0R44C-rad Ab
02/22/20219:12AMPR Newswire (US)Alliance radiation oncology at Anna Jaques hospital becomes a C-RAD total-integration customerLSE:0R44C-rad Ab
02/03/20211:44AMPR Newswire (US)C-RAD and WITH-GLOBAL engage in a partnership for the South Korean marketLSE:0R44C-rad Ab
01/28/20211:47AMPR Newswire (US)Record order intake and revenue leads to increased profit for the quarter and full year : C-RADLSE:0R44C-rad Ab
01/18/20215:12AMPR Newswire (US)C-RAD Web Presentation Year-end Report 2020LSE:0R44C-rad Ab
12/28/20208:30AMPR Newswire (US)C-RAD receives order for proton cancer treatment centers in the USLSE:0R44C-rad Ab
12/23/20206:40AMPR Newswire (US)Shenzhen proton therapy treatment center selects C-RAD Catalystâ„¢ systemLSE:0R44C-rad Ab
09/30/20204:32AMPR Newswire (US)Australian customers select C-RAD's cutting edge SIGRT solutionLSE:0R44C-rad Ab
07/31/20201:42AMPR Newswire (US)C-RAD: Positive operating income in challenging timesLSE:0R44C-rad Ab
06/30/20202:36AMPR Newswire (US)C-RAD is Selected to Equip the Shenzhen Proton Therapy Treatment Center in China With Catalystâ„¢ SystemsLSE:0R44C-rad Ab
05/09/20208:49AMPR Newswire (US)Former Employee Has Filed a Lawsuit for CompensationLSE:0R44C-rad Ab
05/06/20201:44AMPR Newswire (US)C-RAD AB - Interim Report January - March 2020LSE:0R44C-rad Ab
 Showing the most relevant articles for your search:LSE:0R44